These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 27457527

  • 1. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
    Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ.
    J Nucl Cardiol; 2017 Apr; 24(2):413-424. PubMed ID: 27457527
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis.
    Lee PI, Cheng G, Alavi A.
    J Nucl Cardiol; 2017 Feb; 24(1):19-28. PubMed ID: 27813028
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pre-Treatment Myocardial 18FDG Uptake Predicts Response to Immunosuppression in Patients With Cardiac Sarcoidosis.
    Subramanian M, Swapna N, Ali AZ, Saggu DK, Yalagudri S, Kishore J, Swamy LTN, Narasimhan C.
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):2008-2016. PubMed ID: 33454258
    [Abstract] [Full Text] [Related]

  • 7. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
    Wisenberg G, Thiessen JD, Pavlovsky W, Butler J, Wilk B, Prato FS.
    J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
    [Abstract] [Full Text] [Related]

  • 8. FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events.
    Tuominen H, Haarala A, Tikkakoski A, Kähönen M, Nikus K, Sipilä K.
    J Nucl Cardiol; 2021 Feb; 28(1):199-205. PubMed ID: 30815833
    [Abstract] [Full Text] [Related]

  • 9. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
    Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, Hainer J, Murthy VL, Skali H, Dorbala S, Di Carli MF, Blankstein R.
    J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
    [Abstract] [Full Text] [Related]

  • 10. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.
    Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, Govender P, Ruberg FL, Miller EJ.
    J Nucl Cardiol; 2014 Oct; 21(5):925-39. PubMed ID: 24879453
    [Abstract] [Full Text] [Related]

  • 11. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC.
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    Kramer GM, Frings V, Hoetjes N, Hoekstra OS, Smit EF, de Langen AJ, Boellaard R.
    J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.
    Lapa C, Reiter T, Kircher M, Schirbel A, Werner RA, Pelzer T, Pizarro C, Skowasch D, Thomas L, Schlesinger-Irsch U, Thomas D, Bundschuh RA, Bauer WR, Gärtner FC.
    Oncotarget; 2016 Nov 22; 7(47):77807-77814. PubMed ID: 27780922
    [Abstract] [Full Text] [Related]

  • 18. Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
    Rojulpote C, Bhattaru A, Jean C, Adams SL, Patel V, Vidula MK, Selvaraj S, Dubroff J, Peyster E, Clancy CB, Patterson K, Marchlinski FE, Rossman M, Goldberg L, Bravo PE.
    JACC Cardiovasc Imaging; 2022 Nov 22; 15(11):1944-1955. PubMed ID: 36357136
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, Baba K, Ishibashi M, Hayabuchi N, Narula J, Imaizumi T.
    JACC Cardiovasc Imaging; 2010 Dec 22; 3(12):1219-28. PubMed ID: 21163450
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.